Ep 5. The Limits of Cancer Treatements, Limits of Computational Modeling, and some words of wisdom.

On this episode of the BioTEC Pod we are joined by professor Khaled Barakat! Prof.Barakat’s lab is focused on applying computational drug discovery tools to discover new antiviral and immune checkpoints’ small molecule drugs. Prof. Barakat has previously completed his postdoctoral fellowship in the lab of the Nobel Laureate Prof. Michael Houghton. In addition, he serves as the CEO & co-founder of HEKA Therapeutics Inc. and is a co-founder of ACHLYS; two spinoff companies devoted to drug discovery. Learn about the future of cancer treatments, the limits of computational modeling, and spin-off companies with Professor Khaled Barakat. Stay tuned!